NCT04266405

Brief Summary

To assess collagen and zhuyin drink on skin \& body condition improvement

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
26 days until next milestone

Study Start

First participant enrolled

March 9, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

December 11, 2020

Status Verified

December 1, 2020

Enrollment Period

5 months

First QC Date

February 10, 2020

Last Update Submit

December 10, 2020

Conditions

Outcome Measures

Primary Outcomes (10)

  • The change of skin moisture

    Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120

    Change from Baseline skin moisture at 4 weeks

  • The change of skin wrinkles

    VISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units

    Change from Baseline skin wrinkles at 4 weeks

  • The change of skin collagen density

    DermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units:Intensity score

    Change from Baseline skin collagen density at 4 weeks

  • The change of TEWL

    Tewameter® TM 300 was utilized to measure TEWL. Units: g/h/m2

    Change from Baseline TEWL at 4 weeks

  • The change of skin brightness

    Glossymeter GL 200 was utilized to measure skin brightness. Units: arbitrary units

    Change from Baseline skin brightness at 4 weeks

  • The change of interleukin-6

    Venous blood was sampled to measure concentrations of interleukin-6.

    Change from Baseline skin brightness at 4 weeks

  • The change of interleukin-8

    Venous blood was sampled to measure concentrations of interleukin-8.

    Change from Baseline skin brightness at 4 weeks

  • The change of Tumor necrosis factor

    Venous blood was sampled to measure concentrations of Tumor necrosis factor.

    Change from Baseline skin brightness at 4 weeks

  • The change of Matrix metalloproteinase-1

    Venous blood was sampled to measure concentrations of Matrix metalloproteinase-1 .

    Change from Baseline skin brightness at 4 weeks

  • The change of metallopeptidase inhibitor 1

    Venous blood was sampled to measure concentrations of metallopeptidase inhibitor 1.

    Change from Baseline skin brightness at 4 weeks

Secondary Outcomes (4)

  • The change of skin texture

    Change from Baseline skin texture at 4 weeks

  • The change of skin pores

    Change from Baseline skin pores at 4 weeks

  • The change of skin spots

    Change from Baseline skin spots at 4 weeks

  • The change of red areas

    Change from Baseline red areas at 4 weeks

Study Arms (2)

Placebo drink

PLACEBO COMPARATOR
Dietary Supplement: Placebo drink

Collagen and Zhuyin Drinks

EXPERIMENTAL
Dietary Supplement: Collagen Cubilose Drink

Interventions

Placebo drinkDIETARY_SUPPLEMENT

consume 1 bottle (50 mL) per day for 28 days

Placebo drink
Collagen Cubilose DrinkDIETARY_SUPPLEMENT

consume 1 bottle (50 mL) per day for 28 days

Collagen and Zhuyin Drinks

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults aged above 20 years old

You may not qualify if:

  • Subject who is not willing to participate in this study.
  • Patients with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
  • Vegetarian
  • Subjects who have large spots (area \>3 square centimeter) or abnormal acne.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chia Nan University of Pharmacy & Science

Tainan, 71710, Taiwan

Location

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2020

First Posted

February 12, 2020

Study Start

March 9, 2020

Primary Completion

July 31, 2020

Study Completion

December 1, 2020

Last Updated

December 11, 2020

Record last verified: 2020-12

Locations